Elevated cerebrospinal fluid pressure in patients with Alzheimer's disease

por Silverberg, Gerald, Mayo, Martha, Saul, Thomas, Fellmann, Jere, McGuire, Dawn
Publicado 2006

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre‐specified subgroup with heart f...

por Rossignol, Patrick, Williams, Bryan, Mayo, Martha R., Warren, Suzette, Arthur, Susan, Ackourey, Gail, White, William B., Agarwal, Rajiv
Publicado 2020

Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics

por Weir, Matthew R., Mayo, Martha R., Garza, Dahlia, Arthur, Susan A., Berman, Lance, Bushinsky, David, Wilson, Daniel J., Epstein, Murray
Publicado 2017

Optimized Culture Conditions for Improved Growth and Functional Differentiation of Mouse and Human Colon Organoids

por Wilson, Sarah S., Mayo, Martha, Melim, Terry, Knight, Heather, Patnaude, Lori, Wu, Xiaoming, Phillips, Lucy, Westmoreland, Susan, Dunstan, Robert, Fiebiger, Edda, Terrillon, Sonia
Publicado 2021

Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors

por Pitt, Bertram, Bakris, George L., Bushinsky, David A., Garza, Dahlia, Mayo, Martha R., Stasiv, Yuri, Christ‐Schmidt, Heidi, Berman, Lance, Weir, Matthew R.
Publicado 2015

Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers

por Lesko, Lawrence J., Offman, Elliot, Brew, Christine Taylor, Garza, Dahlia, Benton, Wade, Mayo, Martha R., Romero, Alain, Du Mond, Charles, Weir, Matthew R.
Publicado 2017

Long‐term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin‐converting enzymes/angiotensin receptor block...

por Pitt, Bertram, Bakris, George L., Weir, Matthew R., Freeman, Mason W., Lainscak, Mitja, Mayo, Martha R., Garza, Dahlia, Zawadzki, Rezi, Berman, Lance, Bushinsky, David A.
Publicado 2018

Use of QSPR Modeling to Characterize In Vitro Binding of Drugs to a Gut-Restricted Polymer

por Brew, Christine Taylor, Blake, James F., Mistry, Anita, Liu, Fengling, Carreno, Diana, Madsen, Deidre, Mu, YongQi, Mayo, Martha, Stahl, Wilhelm, Matthews, David, Maclean, Derek, Harrison, Steve
Publicado 2018

An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients

por Besarab, Anatole, Zeig, Steven N, Martin, Edouard R, Pergola, Pablo E, Whittier, Frederick C, Zabaneh, Raja I, Schiller, Brigitte, Mayo, Martha, Francisco, Carol A, Polu, Krishna R, Duliege, Anne-Marie
Publicado 2012

NRF2 activator A-1396076 ameliorates inflammation in autoimmune disease models by inhibiting antigen dependent T cell activation

por Goess, Christian, Terrillon, Sonia, Mayo, Martha, Bousquet, Peter, Wallace, Craig, Hart, Michelle, Mathieu, Suzanne, Twomey, Rachel, Donnelly-Roberts, Diana, Namovic, Marian, Jung, Paul, Hu, Min, Richardson, Paul, Esbenshade, Tim, Cuff, Carolyn A.
Publicado 2020